{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:43:30Z","timestamp":1790203410195,"version":"4.1.0"},"reference-count":63,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to explore the reflections of student and newly qualified pharmacists (NQPs) surrounding community pharmacy culture around substance dependency. This study explored professionalism and professional identity formation, and the possibility that a fragmented professional identity may impact behaviours and the provision of compassionate care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Qualitative study: semi\u2010structured interviews were conducted with student and exploring stigma within community pharmacy environments in relation to people with substance dependency, the community pharmacy culture and their own ideas of professionalism and their professional identity formation. Interviews were undertaken by six pharmacy student researchers, under the supervision of two experienced researchers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Community pharmacies across Scotland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      Twenty\u2010eight participants were recruited, including undergraduates based at Scottish Schools of Pharmacy (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920); Foundation Year Pharmacy students (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092) and NQPs (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096). Recruitment utilised university networks and social media platforms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>Interviews were conducted between September and November 2023 on Microsoft Teams\u00ae, each lasting 17\u201360\u2009minutes. Data underwent inductive thematic analysis via NVivo\u00ae through data familiarisation, initial coding, theme searching, reviewing and defining and reporting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Stigmatisation of people with substance dependency attending a pharmacy was a prominent observation. This included negative stereotyping, adverse treatment because of judgements made about substance use and structural stigma relating to barriers to accessing care. Positive care provision in pharmacies was evident. Pharmacy staff who were empathetic, respectful, professional and who formed long\u2010term relationships with people with substance dependency were valuable role models for students and influenced their professional identify formation. Students appreciated the exposure to practice and the opportunity to make judgements that would mould the type of pharmacist they aspired to become. A number of participants reported that their university course poorly prepared them for the reality of supporting people with substance dependency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pharmacy practice in Scotland appears to be characterised by stigma and lack of professionalism towards people with substance dependency, although there are examples of compassionate care. Observing staff in practice allowed participants of this study to develop their own professional identity and attitudes, yet there is a need to better prepare students in undergraduate curricula.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/add.70180","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:00:20Z","timestamp":1758812420000},"page":"138-149","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Professionalism, professional identity and community pharmacy culture: The context of substance dependency through the lens of student and early career pharmacists"],"prefix":"10.1111","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1422-9415","authenticated-orcid":false,"given":"Natalie","family":"Weir","sequence":"first","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Dunlop","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"MacKenzie","sequence":"additional","affiliation":[{"name":"Healthcare Improvement Scotland  Glasgow Scotland UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Byrne","sequence":"additional","affiliation":[{"name":"Healthcare Improvement Scotland  Glasgow Scotland UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Johnston","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"O'Hagan","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohaib","family":"Rehman","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Richardson","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aalia","family":"Shah","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Wilson","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Radley","sequence":"additional","affiliation":[{"name":"School of Health Sciences University of Dundee  Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"World Health Organision.Opioid overdose 2023[cited 2024 August].https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/opioid-overdose#:~:text=Worldwide%2C%20in%202019%20about%20600 deaths%20caused%20by%20opioid%20overdose"},{"key":"e_1_2_10_3_1","unstructured":"RitchieHAP RoserM.Opioids Cocaine Cannabis and Other Illicit Drugs. Published online at OurWorldinData.org: Our World in Data;2022[cited 2025 Feb].https:\/\/ourworldindata.org\/illicit-drug-use"},{"key":"e_1_2_10_4_1","unstructured":"National Records of Scotland.Drug\u2010related Deaths in Scotland in 2023.2024."},{"key":"e_1_2_10_5_1","unstructured":"Public Health Scotland.Estimated quarterly numbers of people prescribed opioid substitution therapy in Scotland (12\u2010month period)2024."},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.11.006"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005764"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-016-0714-y"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(23)00082-8"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.06.023"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2016.07.006"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0327-1"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00517-0"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.06.009"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.03.020"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1256-2"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2022.115230"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2021.1975749"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.12.008"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2012.301069"},{"key":"e_1_2_10_21_1","unstructured":"Council GP.2017Standards for pharmacy professionals."},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/17151635221115370"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.5688\/ajpe8714"},{"key":"e_1_2_10_24_1","first-page":"15","article-title":"Pharmacy student professional identity formation: a scoping review","volume":"8","author":"Noble C","year":"2019","journal-title":"Integr Pharm Res Pract"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cptl.2022.07.010"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riab020"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2022.08.016"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2025.01.017"},{"key":"e_1_2_10_29_1","unstructured":"Council GP.Standards for the initial education and training of pharmacists.2021"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy5020016"},{"key":"e_1_2_10_31_1","unstructured":"National Trauma Transformation Programme.A Roadmap for Creating Trauma\u2010Informed and Responsive Change: Guidance for Organisations Systems and Workforces in Scotland(2023) [cited 2024 August]."},{"key":"e_1_2_10_32_1","unstructured":"Scottish Government.Medication Assisted Treatment (MAT) standards: access choice support.2021."},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/13645579.2018.1454643"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"e_1_2_10_35_1","unstructured":"NHS inform.NHS Pharmacy First Scotland2024[cited 2024 August].https:\/\/www.nhsinform.scot\/campaigns\/nhs-pharmacy-first-scotland\/"},{"key":"e_1_2_10_36_1","unstructured":"NHS England.Pharmacy First2024"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdw138"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000346674"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2008.06.004"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/11782218221118462"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2006.02.010"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/17151635211063188"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31959-1"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/09687637.2012.743506"},{"key":"e_1_2_10_45_1","article-title":"Stigma toward substance use disorders: a multinational perspective and call for action","volume":"15","author":"El Hayek S","year":"2024","journal-title":"Front Psych"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000351"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16031"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2023.100196"},{"key":"e_1_2_10_49_1","unstructured":"World Health Organization.United Nations Office on Drugs and Crime.2020International standards for the treatment of drug use disorders: revised edition incorporating results of field\u2010testin"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01132-5"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/tl.20464"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.25259\/SRJHS_56_2023"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijpp.12521"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy7010023"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cptl.2022.07.014"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1108\/TQM-04-2015-0052"},{"issue":"1","key":"e_1_2_10_57_1","first-page":"1","article-title":"A portrait of the pharmacy profession globally: pharmacist universal professional identity and establishment of global pharmacy council","volume":"13","author":"Ahmer Raza M","year":"2022","journal-title":"Innov Pharm"},{"key":"e_1_2_10_58_1","unstructured":"International Pharmaceutical Federation.FIP Development Goals Transforming global pharmacy.2020."},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2014.12.008"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riac070"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2021.01.005"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1211\/ijpp.14.3.0004"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009180"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11135-017-0574-8"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.70180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:23:51Z","timestamp":1765974231000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.70180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1111\/add.70180"],"URL":"https:\/\/doi.org\/10.1111\/add.70180","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"2024-10-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}